179 related articles for article (PubMed ID: 33070889)
21. Drug-resistant epilepsy in children with partial onset epilepsy treated with carbamazepine.
Aungaroon G; Holland KD; Horn PS; Standridge SM; Imming CM
Int J Neurosci; 2017 Oct; 127(10):849-853. PubMed ID: 27915489
[TBL] [Abstract][Full Text] [Related]
22. Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand.
Viratanapanu I; Romyen C; Chaivanijchaya K; Sornphiphatphong S; Kattipatanapong W; Techagumpuch A; Kitisin K; Pungpapong SU; Tharavej C; Navicharern P; Boonchayaanant P; Udomsawaengsup S
J Obes; 2019; 2019():5383478. PubMed ID: 30863633
[TBL] [Abstract][Full Text] [Related]
23. Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.
Ngan Kee N; Foster E; Marquina C; Tan A; Pang SST; O'Brien TJ; Kwan P; Jackson GD; Chen Z; Ademi Z
Neurology; 2023 May; 100(18):e1866-e1877. PubMed ID: 36927880
[TBL] [Abstract][Full Text] [Related]
24. Perampanel as adjunctive therapy in drug resistant epilepsy in adolescents and children waiting for epilepsy surgery: A multicenter observational study in Thailand.
Suwanpakdee P; Saksritavee B; Likasitthananon N; Simasathien T; Deesudchit T; Khongkhatithum C; Viravan S; Nabangchang C
Seizure; 2022 Aug; 100():103-108. PubMed ID: 35820301
[TBL] [Abstract][Full Text] [Related]
25. Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery.
Bowen JM; Snead OC; Chandra K; Blackhouse G; Goeree R
Ont Health Technol Assess Ser; 2012; 12(18):1-41. PubMed ID: 23074428
[TBL] [Abstract][Full Text] [Related]
26. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
Elliott J; van Katwyk S; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Pharmacoeconomics; 2019 Oct; 37(10):1261-1276. PubMed ID: 31201643
[TBL] [Abstract][Full Text] [Related]
27. Referral to evaluation for epilepsy surgery: Reluctance by epileptologists and patients.
Steinbrenner M; Kowski AB; Holtkamp M
Epilepsia; 2019 Feb; 60(2):211-219. PubMed ID: 30653659
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
Vera-Llonch M; Brandenburg NA; Oster G
Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
[TBL] [Abstract][Full Text] [Related]
29. Health care costs decline after successful epilepsy surgery.
Langfitt JT; Holloway RG; McDermott MP; Messing S; Sarosky K; Berg AT; Spencer SS; Vickrey BG; Sperling MR; Bazil CW; Shinnar S
Neurology; 2007 Apr; 68(16):1290-8. PubMed ID: 17438219
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
Nass RD; Kurth C; Kull A; Graf W; Kasper B; Hamer HM; Strzelczyk A; Elger CE; Steinhoff BJ; Surges R; Rosenow F
Epilepsy Behav; 2016 Mar; 56():54-8. PubMed ID: 26828693
[TBL] [Abstract][Full Text] [Related]
31. Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy.
Ishikawa N; Tateishi Y; Tani H; Kobayashi Y; Kobayashi M
Epilepsy Behav; 2019 May; 94():82-86. PubMed ID: 30897534
[TBL] [Abstract][Full Text] [Related]
32. Family resources moderate the relationship between seizure control and health-related quality of life in children with drug-resistant epilepsy.
Phillips NL; Widjaja E; Smith ML
Epilepsia; 2020 Aug; 61(8):1638-1648. PubMed ID: 32640091
[TBL] [Abstract][Full Text] [Related]
33. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis for the use of serum antiepileptic drug level monitoring in children diagnosed with structural-metabolic epilepsy.
Salih MR; Bahari MB; Shafie AA; Hassali MA; Al-Lela OQ; Abd AY; Ganesan VM
Epilepsy Res; 2013 Mar; 104(1-2):151-7. PubMed ID: 23103061
[TBL] [Abstract][Full Text] [Related]
35. Preoperative evaluation and surgical management of infants and toddlers with drug-resistant epilepsy.
Pindrik J; Hoang N; Smith L; Halverson M; Wojnaroski M; McNally K; Gedela S; Ostendorf AP
Neurosurg Focus; 2018 Sep; 45(3):E3. PubMed ID: 30173613
[TBL] [Abstract][Full Text] [Related]
36. Cost analysis of epilepsy surgery and of vigabatrin treatment in patients with refractory partial epilepsy.
Malmgren K; Hedström A; Granqvist R; Malmgren H; Ben-Menachem E
Epilepsy Res; 1996 Nov; 25(3):199-207. PubMed ID: 8956917
[TBL] [Abstract][Full Text] [Related]
37. A Cost-Effectiveness Comparison Between Open Transforaminal and Minimally Invasive Lateral Lumbar Interbody Fusions Using the Incremental Cost-Effectiveness Ratio at 2-Year Follow-up.
Gandhoke GS; Shin HM; Chang YF; Tempel Z; Gerszten PC; Okonkwo DO; Kanter AS
Neurosurgery; 2016 Apr; 78(4):585-95. PubMed ID: 26726969
[TBL] [Abstract][Full Text] [Related]
38. Seizure freedom improves health-related quality of life after epilepsy surgery in children.
Jain P; Smith ML; Speechley K; Ferro M; Connolly M; Ramachandrannair R; Almubarak S; Andrade A; Widjaja E;
Dev Med Child Neurol; 2020 May; 62(5):600-608. PubMed ID: 31709524
[TBL] [Abstract][Full Text] [Related]
39. Retigabine as add-on treatment of refractory epilepsy--a cost-utility study in a Swedish setting.
Kristian B; Wachtmeister K; Stefan F; Forsgren L
Acta Neurol Scand; 2013 Jun; 127(6):419-26. PubMed ID: 23368976
[TBL] [Abstract][Full Text] [Related]
40. [Surgical treatment of epilepsy: outcome of various surgical procedures in adults and children].
Guénot M
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S241-50. PubMed ID: 15331972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
